Lamendola C[au] - Search Results

Year	Number of Results
1989	1
1990	2
1992	1
1993	1
1996	1
1999	4
2000	5
2001	6
2002	7
2003	5
2004	7
2005	4
2006	5
2007	8
2008	7
2009	8
2010	5
2011	4
2012	1
2013	3
2014	6
2015	6
2016	2
2017	2
2018	3
2019	1
2020	1
2021	1
2022	0

1

Risk factors for type 2 diabetes mellitus.

Fletcher B, Gulanick M, Lamendola C. Fletcher B, et al. Among authors: lamendola c. J Cardiovasc Nurs. 2002 Jan;16(2):17-23. doi: 10.1097/00005082-200201000-00003. J Cardiovasc Nurs. 2002. PMID: 11800065 Review.

2

Statins Are Associated With Increased Insulin Resistance and Secretion.

Abbasi F, Lamendola C, Harris CS, Harris V, Tsai MS, Tripathi P, Abbas F, Reaven GM, Reaven PD, Snyder MP, Kim SH, Knowles JW. Abbasi F, et al. Among authors: lamendola c. Arterioscler Thromb Vasc Biol. 2021 Nov;41(11):2786-2797. doi: 10.1161/ATVBAHA.121.316159. Epub 2021 Aug 26. Arterioscler Thromb Vasc Biol. 2021. PMID: 34433298 Free article. Clinical Trial.

3

Insulin resistance syndrome.

Fletcher B, Lamendola C. Fletcher B, et al. Among authors: lamendola c. J Cardiovasc Nurs. 2004 Sep-Oct;19(5):339-45. doi: 10.1097/00005082-200409000-00009. J Cardiovasc Nurs. 2004. PMID: 15495894 Review.

4

Early and more vigorous detection of diabetes.

Lamendola C. Lamendola C. J Cardiovasc Nurs. 2003 Apr-Jun;18(2):103-7. doi: 10.1097/00005082-200304000-00005. J Cardiovasc Nurs. 2003. PMID: 12680568 Review.

5

American Heart Association Diabetes and Cardiometabolic Health Summit: Summary and Recommendations.

Sasson C, Eckel R, Alger H, Bozkurt B, Carson A, Daviglus M, Deedwania P, Kirley K, Lamendola C, Nguyen M, Rajgopal Singh R, Wang T, Sanchez E. Sasson C, et al. Among authors: lamendola c. J Am Heart Assoc. 2018 Aug 7;7(15):e009271. doi: 10.1161/JAHA.118.009271. J Am Heart Assoc. 2018. PMID: 30371251 Free PMC article. No abstract available.

6

The relationship between insulin resistance and dyslipidaemia in cigarette smokers.

Farin HM, Abbasi F, Kim SH, Lamendola C, McLaughlin T, Reaven GM. Farin HM, et al. Among authors: lamendola c. Diabetes Obes Metab. 2007 Jan;9(1):65-9. doi: 10.1111/j.1463-1326.2006.00574.x. Diabetes Obes Metab. 2007. PMID: 17199720

7

Safety, efficacy and pharmacokinetics of repeat subcutaneous dosing of avexitide (exendin 9-39) for treatment of post-bariatric hypoglycaemia.

Tan M, Lamendola C, Luong R, McLaughlin T, Craig C. Tan M, et al. Among authors: lamendola c. Diabetes Obes Metab. 2020 Aug;22(8):1406-1416. doi: 10.1111/dom.14048. Epub 2020 May 4. Diabetes Obes Metab. 2020. PMID: 32250530

8

Access to Innovative Medicine: A Preventive Cardiovascular Nurses Association Position Statement to Reduce the Barriers.

Lamendola C, Champagne MA, Nelson Worel J, Coke LA. Lamendola C, et al. J Cardiovasc Nurs. 2018 May/Jun;33(3):199-201. doi: 10.1097/JCN.0000000000000492. J Cardiovasc Nurs. 2018. PMID: 29634645 No abstract available.

9

Lipoprotein abnormalities are associated with insulin resistance in South Asian Indian women.

Palaniappan LP, Kwan AC, Abbasi F, Lamendola C, McLaughlin TL, Reaven GM. Palaniappan LP, et al. Among authors: lamendola c. Metabolism. 2007 Jul;56(7):899-904. doi: 10.1016/j.metabol.2007.01.020. Metabolism. 2007. PMID: 17570249

10

Dietary weight loss in insulin-resistant non-obese humans: Metabolic benefits and relationship to adipose cell size.

McLaughlin T, Abbasi F, Lamendola C, Yee G, Carter S, Cushman SW. McLaughlin T, et al. Among authors: lamendola c. Nutr Metab Cardiovasc Dis. 2019 Jan;29(1):62-68. doi: 10.1016/j.numecd.2018.09.014. Epub 2018 Oct 11. Nutr Metab Cardiovasc Dis. 2019. PMID: 30497926 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results